D'or Instituto de Pesquisa e Educação

São Paulo

0 studies enrolling now · 1 studies all time

What they study most

Non-Hodgkin Lymphoma

Studies at this site

• A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma — Running, not enrolling